Viridian Therapeutics, Inc.\DE (VRDN) Receivables - Other (2016 - 2025)
Historic Receivables - Other for Viridian Therapeutics, Inc.\DE (VRDN) over the last 8 years, with Q3 2025 value amounting to $70.0 million.
- Viridian Therapeutics, Inc.\DE's Receivables - Other rose 49990000.0% to $70.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $70.0 million, marking a year-over-year increase of 49990000.0%. This contributed to the annual value of $102000.0 for FY2023, which is 0.0% changed from last year.
- Per Viridian Therapeutics, Inc.\DE's latest filing, its Receivables - Other stood at $70.0 million for Q3 2025, which was up 49990000.0% from $14000.0 recorded in Q3 2024.
- Over the past 5 years, Viridian Therapeutics, Inc.\DE's Receivables - Other peaked at $70.0 million during Q3 2025, and registered a low of $14000.0 during Q3 2024.
- Its 5-year average for Receivables - Other is $5.6 million, with a median of $128000.0 in 2023.
- As far as peak fluctuations go, Viridian Therapeutics, Inc.\DE's Receivables - Other tumbled by 8627.45% in 2024, and later skyrocketed by 49990000.0% in 2025.
- Quarter analysis of 5 years shows Viridian Therapeutics, Inc.\DE's Receivables - Other stood at $451000.0 in 2021, then plummeted by 77.38% to $102000.0 in 2022, then changed by 0.0% to $102000.0 in 2023, then plummeted by 86.27% to $14000.0 in 2024, then soared by 499900.0% to $70.0 million in 2025.
- Its Receivables - Other stands at $70.0 million for Q3 2025, versus $14000.0 for Q3 2024 and $102000.0 for Q1 2024.